Management Of Stroke

• The risk of recurrent stroke after TIA or minor stroke is higher than previously thought

• The early risk of recurrent stroke can be calculated using a simple clinical score, the ‘ABCD’ score

• The MATCH trial has shown no additional benefit with clopidogrel and aspirin over clopidogrel alone in prevention of recurrent stroke or vascular events

• The ESPRIT trial has shown benefit of aspirin and dipyridamole over aspirin alone in the secondary prevention of stroke

• The efficacy of carotid surgery for secondary prevention of stroke in patients with symptomatic carotid stenosis is highly dependent on the timing of surgery

There are various clinical and pathological subtypes of stroke, and identification of the subtype is necessary for correct management.